Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C24H36N4O6S2 |
Molecular Weight | 540.696 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12CC(=O)N[C@H](C(C)C)C(=O)N[C@]([H])(CSSCC\C=C\1)C(=O)N\C(=C/C)C(=O)N[C@@H](C(C)C)C(=O)O2
InChI
InChIKey=OHRURASPPZQGQM-GCCNXGTGSA-N
InChI=1S/C24H36N4O6S2/c1-6-16-21(30)28-20(14(4)5)24(33)34-15-9-7-8-10-35-36-12-17(22(31)25-16)26-23(32)19(13(2)3)27-18(29)11-15/h6-7,9,13-15,17,19-20H,8,10-12H2,1-5H3,(H,25,31)(H,26,32)(H,27,29)(H,28,30)/b9-7+,16-6-/t15-,17-,19-,20+/m1/s1
DescriptionSources: https://pubmed.ncbi.nlm.nih.gov/26331334
Sources: https://pubmed.ncbi.nlm.nih.gov/26331334
FR-135313 (also known as Romidepsin reduced) was studied as a selective inhibitor of the human histone deacetylase 1 (HDAC1).
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: Q13547 Gene ID: 3065.0 Gene Symbol: HDAC1 Target Organism: Homo sapiens (Human) Sources: https://pubmed.ncbi.nlm.nih.gov/26331334 |
0.12 nM [IC50] |
Sample Use Guides
In Vitro Use Guide
Sources: https://pubmed.ncbi.nlm.nih.gov/26331334
Inhibition of recombinant human HDAC1 after 60 mins by fluorescence assay with IC50 = 0.00012 uM
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
193404
Created by
admin on Fri Dec 15 15:47:36 GMT 2023 , Edited by admin on Fri Dec 15 15:47:36 GMT 2023
|
||
|
EMA ASSESSMENT REPORTS |
ISTODAX (REFUSED: LYMPHOMA, NON-HODGKIN)
Created by
admin on Fri Dec 15 15:47:36 GMT 2023 , Edited by admin on Fri Dec 15 15:47:36 GMT 2023
|
||
|
NCI_THESAURUS |
C1946
Created by
admin on Fri Dec 15 15:47:36 GMT 2023 , Edited by admin on Fri Dec 15 15:47:36 GMT 2023
|
||
|
WHO-ATC |
L01XX39
Created by
admin on Fri Dec 15 15:47:36 GMT 2023 , Edited by admin on Fri Dec 15 15:47:36 GMT 2023
|
||
|
LIVERTOX |
NBK548380
Created by
admin on Fri Dec 15 15:47:36 GMT 2023 , Edited by admin on Fri Dec 15 15:47:36 GMT 2023
|
||
|
NDF-RT |
N0000175588
Created by
admin on Fri Dec 15 15:47:36 GMT 2023 , Edited by admin on Fri Dec 15 15:47:36 GMT 2023
|
||
|
WHO-VATC |
QL01XX39
Created by
admin on Fri Dec 15 15:47:36 GMT 2023 , Edited by admin on Fri Dec 15 15:47:36 GMT 2023
|
||
|
NCI_THESAURUS |
C1976
Created by
admin on Fri Dec 15 15:47:36 GMT 2023 , Edited by admin on Fri Dec 15 15:47:36 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
8656
Created by
admin on Fri Dec 15 15:47:36 GMT 2023 , Edited by admin on Fri Dec 15 15:47:36 GMT 2023
|
PRIMARY | |||
|
m9652
Created by
admin on Fri Dec 15 15:47:36 GMT 2023 , Edited by admin on Fri Dec 15 15:47:36 GMT 2023
|
PRIMARY | Merck Index | ||
|
630176
Created by
admin on Fri Dec 15 15:47:36 GMT 2023 , Edited by admin on Fri Dec 15 15:47:36 GMT 2023
|
PRIMARY | |||
|
SUB26362
Created by
admin on Fri Dec 15 15:47:36 GMT 2023 , Edited by admin on Fri Dec 15 15:47:36 GMT 2023
|
PRIMARY | |||
|
SS-77
Created by
admin on Fri Dec 15 15:47:36 GMT 2023 , Edited by admin on Fri Dec 15 15:47:36 GMT 2023
|
PRIMARY | |||
|
CX3T89XQBK
Created by
admin on Fri Dec 15 15:47:36 GMT 2023 , Edited by admin on Fri Dec 15 15:47:36 GMT 2023
|
PRIMARY | |||
|
EU/3/05/279(POSITIVE)
Created by
admin on Fri Dec 15 15:47:36 GMT 2023 , Edited by admin on Fri Dec 15 15:47:36 GMT 2023
|
PRIMARY | On 27 May 2005, orphan designation (EU/3/05/279) was granted by the European Commission to The Matthews Consultancy Ltd, United Kingdom, for (E)-(1S,4S,10S,21R)-7-[(Z)-ethylidene]-4,21-diisopropyl-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone (depsipeptide) for the treatment of cutaneous T cell lymphoma. The sponsorship was transferred to Gloucester Pharmaceuticals Limited, United Kingdom, in October 2008 and to Celgene Europe Limited, United Kingdom, in September 2010. | ||
|
61080
Created by
admin on Fri Dec 15 15:47:36 GMT 2023 , Edited by admin on Fri Dec 15 15:47:36 GMT 2023
|
PRIMARY | |||
|
C087123
Created by
admin on Fri Dec 15 15:47:36 GMT 2023 , Edited by admin on Fri Dec 15 15:47:36 GMT 2023
|
PRIMARY | |||
|
EU/3/05/328(POSITIVE)
Created by
admin on Fri Dec 15 15:47:36 GMT 2023 , Edited by admin on Fri Dec 15 15:47:36 GMT 2023
|
PRIMARY | On 28 October 2005, orphan designation (EU/3/05/328) was granted by the European Commission to The Matthews Consultancy Ltd, United Kingdom, for (E)-(1S,4S,10S,21R)-7-[(Z)-ethylidene]-4,21-diisopropyl-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone (also known as “depsipeptide”) for the for the treatment of peripheral T-cell lymphoma (nodal, other extranodal and leukaemic/disseminated). The sponsorship was transferred to Gloucester Pharmaceuticals Limited, United Kingdom, in October 2008 and to Celgene Europe Limited, United Kingdom, in September 2010. | ||
|
CHEMBL1213490
Created by
admin on Fri Dec 15 15:47:36 GMT 2023 , Edited by admin on Fri Dec 15 15:47:36 GMT 2023
|
PRIMARY | |||
|
7006
Created by
admin on Fri Dec 15 15:47:36 GMT 2023 , Edited by admin on Fri Dec 15 15:47:36 GMT 2023
|
PRIMARY | |||
|
100000091284
Created by
admin on Fri Dec 15 15:47:36 GMT 2023 , Edited by admin on Fri Dec 15 15:47:36 GMT 2023
|
PRIMARY | |||
|
CX3T89XQBK
Created by
admin on Fri Dec 15 15:47:36 GMT 2023 , Edited by admin on Fri Dec 15 15:47:36 GMT 2023
|
PRIMARY | |||
|
877510
Created by
admin on Fri Dec 15 15:47:36 GMT 2023 , Edited by admin on Fri Dec 15 15:47:36 GMT 2023
|
PRIMARY | RxNorm | ||
|
DTXSID8048579
Created by
admin on Fri Dec 15 15:47:36 GMT 2023 , Edited by admin on Fri Dec 15 15:47:36 GMT 2023
|
PRIMARY | |||
|
ROMIDEPSIN
Created by
admin on Fri Dec 15 15:47:36 GMT 2023 , Edited by admin on Fri Dec 15 15:47:36 GMT 2023
|
PRIMARY | |||
|
C1544
Created by
admin on Fri Dec 15 15:47:36 GMT 2023 , Edited by admin on Fri Dec 15 15:47:36 GMT 2023
|
PRIMARY | |||
|
5352062
Created by
admin on Fri Dec 15 15:47:36 GMT 2023 , Edited by admin on Fri Dec 15 15:47:36 GMT 2023
|
PRIMARY | |||
|
DB06176
Created by
admin on Fri Dec 15 15:47:36 GMT 2023 , Edited by admin on Fri Dec 15 15:47:36 GMT 2023
|
PRIMARY | |||
|
4119
Created by
admin on Fri Dec 15 15:47:36 GMT 2023 , Edited by admin on Fri Dec 15 15:47:36 GMT 2023
|
PRIMARY | |||
|
128517-07-7
Created by
admin on Fri Dec 15 15:47:36 GMT 2023 , Edited by admin on Fri Dec 15 15:47:36 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD